Metoprolol succinate and Graft versus host disease - a phase IV clinical study of FDA data

Summary:

Graft versus host disease is reported as a side effect among people who take Metoprolol succinate (metoprolol succinate), especially for people who are male, 60+ old, also take Prednisone, and have Chronic myeloid leukaemia.

The phase IV clinical study analyzes which people have Graft versus host disease when taking Metoprolol succinate. It is created by eHealthMe based on reports of 64,247 people who have side effects when taking Metoprolol succinate from the FDA, and is updated regularly.

What is Metoprolol succinate?

Metoprolol succinate has active ingredients of metoprolol succinate. It is often used in high blood pressure. eHealthMe is studying from 66,933 Metoprolol succinate users. Check the latest studies of Metoprolol succinate.

What is Graft versus host disease?

Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body) is found to be associated with 498 drugs and 642 conditions by eHealthMe. Check the latest studies of Graft versus host disease.



On Jul, 06, 2026

64,247 people reported to have side effects when taking Metoprolol succinate.
Among them, 42 people (0.07%) have Graft versus host disease.

Could Metoprolol succinate cause Graft versus host disease?

Among these 42 people:

What is the gender of people who have Graft versus host disease when taking Metoprolol succinate? *

  • female: 28.95 %
  • male: 71.05 %

What is the age of people who have Graft versus host disease when taking Metoprolol succinate? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 14.81 %
  • 30-39: 3.7 %
  • 40-49: 0.0 %
  • 50-59: 37.04 %
  • 60+: 44.44 %

What are other drugs people take besides Metoprolol succinate? *

  1. Folic Acid: 11 people, 26.19%
  2. Tacrolimus: 11 people, 26.19%
  3. Prednisone: 11 people, 26.19%
  4. Valtrex: 9 people, 21.43%
  5. Acyclovir: 8 people, 19.05%
  6. Levofloxacin: 7 people, 16.67%
  7. Bactrim: 7 people, 16.67%
  8. Revlimid: 6 people, 14.29%
  9. Levothyroxine Sodium: 6 people, 14.29%
  10. Hydrocortisone: 6 people, 14.29%

What are other side effects people have besides Graft versus host disease? *

  1. Weakness: 8 people, 19.05%
  2. Diarrhea: 8 people, 19.05%
  3. Sepsis (a severe blood infection that can lead to organ failure and death): 7 people, 16.67%
  4. Rashes (redness): 7 people, 16.67%
  5. Disease Progression: 5 people, 11.90%
  6. Nausea And Vomiting: 5 people, 11.90%
  7. Nausea (feeling of having an urge to vomit): 5 people, 11.90%
  8. Heart Rate Increased: 5 people, 11.90%
  9. Staphylococcal Infection (an infection with staphylococcus bacteria): 4 people, 9.52%
  10. Acute Graft Versus Host Disease In Skin (acute complication on skin following an allogeneic tissue/blood transplant): 4 people, 9.52%

What are the existing conditions these people have? *

  1. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 5 people, 11.90%
  2. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 4 people, 9.52%
  3. Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 3 people, 7.14%
  4. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 7.14%
  5. Nephrogenic Anaemia (anaemia due to kidney disease): 3 people, 7.14%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 7.14%
  7. Headache (pain in head): 3 people, 7.14%
  8. Dyspnea (difficult or laboured breathing): 2 people, 4.76%
  9. Asthma: 1 person, 2.38%
  10. Cardiac Failure: 1 person, 2.38%

* Approximation only. Some reports may have incomplete information.

Do you take Metoprolol succinate and have Graft versus host disease?

- Check whether Graft versus host disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Metoprolol succinate:

Graft versus host disease treatments and more:

How severe was Graft versus host disease and when was it recovered:

Expand to all the drugs that have ingredients of metoprolol succinate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Metoprolol succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Graft versus host disease:

Browse all the conditions that are associated with Graft versus host disease:


How the study uses the data?

The study uses data from the FDA. It is based on metoprolol succinate (the active ingredients of Metoprolol succinate) and Metoprolol succinate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: